PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
Position in RPRX — Royalty Pharma plc
CIK 1238990
EDINA, MN
Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,526,383
+$4,810,726 QoQ
Shares Held
597,938
-0.1% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#81
of 646 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. holds $41,450,025 across 2 Biotechnology names. RPRX ranks #1 (80.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
597,938 | $33,526,383 | |
| 2 | MDXG |
Mimedx Group, Inc.
|
2,058,089 | $7,923,642 |
All Filings in RPRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,526,383 | 597,938 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,715,657 | 598,617 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,190,414 | 600,166 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,023,034 | 595,891 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,472,546 | 595,963 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,856,261 | 573,603 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,046,153 | 472,213 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,043,132 | 461,051 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,195,146 | 424,541 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,203,978 | 368,916 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||